Last reviewed · How we verify

NCT04744961

Effect of Surgical Site Infections on Patient Reported Cosmetic Outcomes in Dermatologic Surgery

Completed Last updated 18 May 2021
What this trial tests

trial testing SCAR-Q survey in Surgical Site Infection in 114 participants. Completed in 17 May 2021.

Timeline
24 February 2021
Primary endpoint
17 May 2021
17 May 2021

Quick facts

Lead sponsorRegion Skane
StatusCompleted
Study typeOBSERVATIONAL
Enrollment114
Start date24 February 2021
Primary completion17 May 2021
Estimated completion17 May 2021
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Region Skane — full company profile →

Who can join

18 and older, any sex, with Surgical Site Infection or Patient Satisfaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study involves surveying two matched groups of patients that underwent dermatologic surgery at our department. One group had a documented surgical site infection and the other didn't. All patients will be asked to complete a questionnaire in which they assess the physical appearance of their scars and its psychosocial impact. Results will be compared between the groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Surgical Site Infection

Currently open trials in the same condition.

Other Region Skane trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04744961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing